Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
For advanced NSCLC, immunotherapy (especially pembrolizumab) is highly effective for high PD-L1 tumors, while chemotherapy remains a backbone; combining both may improve outcomes.
In nonsquamous advanced NSCLC, camrelizumab was linked to a higher risk of disease progression and death than pembrolizumab in second-line or later treatment, based on one…
Stereotactic radiotherapy (SRT) is a precise treatment that controls tumors and protects brain function, serving as a standard option for patients with one to four brain…
Global disparities in access to new NSCLC therapies stem from differences in drug approval, cost, testing infrastructure, and healthcare system resources.
High PD-L1 expression (≥50%) often makes immunotherapy, such as pembrolizumab, a first-line option for advanced NSCLC, but other factors like mutations also guide treatment.
Mobile health interventions like just-in-time adaptive interventions, online mindfulness-based cognitive behavioral therapy, and smartphone apps show promise for improving youth…
Spirituality acts as a protective factor for youth mental health by improving life satisfaction and self-control, which helps regulate emotions and behaviors.
Yes, real-world data from over 17,500 patients shows pembrolizumab is effective as first-line treatment for advanced NSCLC with high PD-L1 (≥50%), with median overall survival of…
The PI3K/Akt-mTOR pathway is a central signal network that helps your immune cells fight infection, but germs also try to block it to survive.
Research shows that low Vitamin D levels are linked to a higher risk of depression in women compared to men, with studies finding stronger associations specifically in female…
Explainable AI helps doctors see exactly why an AI model suggests a specific infectious disease diagnosis, reducing errors from 'black-box' models and building trust in complex…
For STEMI with multivessel disease, immediate and staged revascularization show similar outcomes overall, but staged may be safer in patients with heart failure or cardiogenic…
For most patients with STEMI and multivessel disease, immediate and staged revascularization have similar risks of death or heart attack, but staged may reduce the need for…
Immediate surgery does not improve outcomes for all STEMI patients with multivessel disease, and it may increase risks for those with heart failure.
Yes, symptom distress — including post-dialysis fatigue, itching, anxiety, and depression — significantly reduces quality of life in hemodialysis patients.
Yes, changes in immune cells and their energy metabolism can predict outcomes like rejection and infection risk in liver transplant recipients.
Yes, a post-hoc analysis of the AFIRE trial found that in patients with atrial fibrillation and stable CAD, lower baseline systolic blood pressure (≤126 mmHg) was linked to…
Yes, recent trials show endovascular thrombectomy improves functional outcomes in patients with large vessel occlusion and low ASPECTS (≤5), though risks remain.
Doctors use clinical scores, imaging, and biomarkers to predict futile LVO stroke treatment, but no single tool is perfect.
Recent reviews show MASLD is the leading cause of chronic liver disease, drives liver transplant needs, and involves complex links between gut bacteria, circadian rhythms, and…
Direct transfer to an angiography suite for severe large vessel occlusion stroke does not improve long-term recovery and may increase the risk of bleeding complications.
Recent reviews highlight lifestyle changes and emerging drugs like resmetirom, but no universally validated treatment exists yet for MASLD.
Capnography shows high diagnostic accuracy for detecting diabetic ketoacidosis by showing significantly lower carbon dioxide levels in affected patients compared to those without…
A 2024 trial found that taking CN-105 before noncardiac surgery reduced serious adverse events in older adults compared to a placebo.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.